Skip to main content
UniHealth

Doctor search

Lidia Kletchikova Brown, MD

Neurology · San Jose

NPI 1417169491

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
10
2 carriers
Office
1

Offices

1 location · El Camino Health Medical Network LLC · 202 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health. That is not proof they admit you there this week.

Plans that list them

10 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brown’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

10 of 10 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A97089 · Current

Licensed to practise in California · since 2006 · expires 2028-05-31 · Saint Petersburg State I.P. Pavlov Medical University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Illinois 036117540Licensed Physician And Surgeon · since 2007 · expires 2014-07-31
    Not RenewedNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%

Original Medicare doctor bills

$64,736

Medicare paid this office $64,736 for 259 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
New patient visit (60+ min)123$21,622$176
Botox14$20,117None
Return visit (30+ min)47$5,006$91
Long return visit (40+ min)25$3,972$153
New patient visit (45+ min)28$3,540$126
See all 8 services
Every Original Medicare service billed
New patient visit (60+ min)123$21,622$176
Botox14$20,117None
Return visit (30+ min)47$5,006$91
Long return visit (40+ min)25$3,972$153
New patient visit (45+ min)28$3,540$126
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face13$2,689$128
Nerve test11$1,599$145
Short return visit (20+ min)11$582$53

Who their Medicare patients are

259 Original Medicare patients in 2024. Average age 75 · Women 61% · Also on Medicaid 13% · Health risk score 1.10. At or below the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 66% · Depression 28% · Diabetes 22% · Coronary heart disease 20% · Atrial fibrillation 19% · Cancer 17% · Chronic kidney disease 16% · Stroke 15% · COPD 13% · Heart failure 11% · Dementia 11%.

The office billed $255,238, Medicare allowed $89,415 and paid $64,736; for 4,599 services of 26 kinds; $20,122 of it was for drugs given in the office and $44,614 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242594,599751.10$255,238$64,736
20232602,645761.17$254,165$68,239
20222783,427791.19$332,483$99,295
20212962,281771.23$362,948$102,427
20202273,921791.27$293,027$77,026
20192645,437771.54$358,320$92,508
20182385,842781.34$314,213$79,372
20172324,630771.43$265,123$66,207
2016230430771.51$84,913$42,832
2015209454781.68$78,627$43,770
2014197407791.42$78,318$41,480
2013239551781.55$75,853$52,062

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
New patient visit (60+ min)83$16,068$194
Return visit (30+ min)88$13,084$111
Long return visit (40+ min)49$7,765$139
Initial hospital care with moderate level of medical decision making at least 75 minutes30$4,878$157
New patient visit (45+ min)19$2,757$145
Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report19$2,394$92
Telephone medical discussion with physician, 21-30 minutes16$2,196$110

2022: 9 services

Original Medicare services billed in 2022
Return visit (30+ min)117$20,951$117
New patient visit (60+ min)86$17,112$199
Long return visit (40+ min)78$15,551$167
Telephone medical discussion with physician, 21-30 minutes52$9,723$120
Initial hospital care with moderate level of medical decision making at least 75 minutes33$5,801$176
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$4,407$92
Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report24$2,541$91
New patient visit (60+ min)14$2,310$165
Measurement of brain wave activity (eeg), 61-119 minutes17$1,519$80

2021: 15 services

Original Medicare services billed in 2021
Return visit (30+ min)114$23,235$116
New patient visit (60+ min)81$15,940$197
Long return visit (40+ min)72$14,827$163
Initial hospital care with moderate level of medical decision making at least 75 minutes46$8,838$173
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes32$5,985$92
Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report32$4,896$92
Telephone medical discussion with physician, 21-30 minutes24$3,355$124
Short return visit (20+ min)33$2,690$75
New patient visit (60+ min)12$2,021$168
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes22$1,756$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes14$1,719$123
Measurement of brain wave activity (eeg), 61-119 minutes21$1,716$78
New patient visit (45+ min)13$1,673$129
Telephone medical discussion with physician, 11-20 minutes12$1,143$82
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$994$90

2020: 10 services

Original Medicare services billed in 2020
Long return visit (40+ min)80$13,590$124
Return visit (30+ min)72$11,453$101
New patient visit (60+ min)58$10,660$184
Initial hospital care with moderate level of medical decision making at least 75 minutes32$5,722$173
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$4,334$92
Telephone medical discussion with physician, 11-20 minutes22$2,115$73
New patient visit (45+ min)12$1,700$142
Measurement of brain wave activity (eeg), 61-119 minutes12$1,310$82
Short return visit (20+ min)14$1,052$70
Telephone medical discussion with physician, 5-10 minutes13$561$43

2019: 8 services

Original Medicare services billed in 2019
Long return visit (40+ min)114$24,215$131
Botox12$23,375None
New patient visit (60+ min)89$16,741$188
Return visit (30+ min)51$5,915$90
Initial hospital care with moderate level of medical decision making at least 75 minutes28$5,086$182
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$4,201$93
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face11$3,063$128
Measurement of brain wave activity (eeg), 61-119 minutes20$2,005$80

2018: 9 services

Original Medicare services billed in 2018
Botox13$25,769None
Return visit (30+ min)89$13,070$91
New patient visit (60+ min)63$11,467$182
Long return visit (40+ min)49$6,499$123
New patient visit (45+ min)44$5,961$135
Initial hospital care with moderate level of medical decision making at least 75 minutes26$4,540$175
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face13$3,367$125
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$2,337$90
Short return visit (20+ min)11$636$53

2017: 6 services

Original Medicare services billed in 2017
New patient visit (45+ min)82$11,275$138
Return visit (30+ min)78$10,551$93
Long return visit (40+ min)32$3,972$124
New patient visit (60+ min)21$3,773$180
Short return visit (20+ min)33$2,818$66
New patient visit (30+ min)26$2,222$85

2016: 6 services

Original Medicare services billed in 2016
Return visit (30+ min)91$13,534$92
New patient visit (45+ min)70$10,083$144
Initial hospital care with moderate level of medical decision making at least 75 minutes51$8,901$171
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes29$2,408$62
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$1,423$89
Short return visit11$664$21

2015: 9 services

Original Medicare services billed in 2015
Return visit (30+ min)79$13,594$98
Initial hospital care with moderate level of medical decision making at least 75 minutes44$8,139$181
New patient visit (45+ min)41$5,920$144
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes32$3,883$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,564$122
New patient visit (30+ min)26$2,518$97
Short return visit (20+ min)22$1,685$62
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes11$1,115$93
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes11$591$35

2014: 7 services

Original Medicare services billed in 2014
Return visit (30+ min)81$14,436$95
New patient visit (45+ min)75$10,413$139
Initial hospital care with moderate level of medical decision making at least 75 minutes28$4,955$177
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes17$2,010$91
Short return visit (20+ min)27$1,999$56
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes18$1,499$62
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,387$116

2013: 10 services

Original Medicare services billed in 2013
Return visit (30+ min)87$12,662$91
New patient visit (45+ min)83$11,181$135
Initial hospital care with moderate level of medical decision making at least 75 minutes35$5,820$166
Short return visit (20+ min)43$4,081$63
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes46$4,025$59
New patient visit (60+ min)20$3,515$176
Long return visit (40+ min)23$3,119$125
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$2,129$85
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes18$2,032$113
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes24$1,442$32

Drugs they prescribed that Part D paid

$39,685

Pharmacies billed $39,685 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 507) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.

489 generic and 18 brand-name prescriptions · $39,685 in drug cost · 18 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Memantine110$4,239$39
Carbidopa-Levodopa43$1,092$25
Donepezil Hcl Odt38$808$21
Gabapentin42$750$18
Propranolol18$481$27
See all 11 drugs
Every Part D drug this clinician prescribed
Memantine110$4,239$39
Carbidopa-Levodopa43$1,092$25
Donepezil Hcl Odt38$808$21
Gabapentin42$750$18
Propranolol18$481$27
Pregabalin22$418$19
Donepezil23$320$14
Atorvastatin18$306$17
Trazodone17$204$12
Levetiracetam13$172$13
Rizatriptan12$53$4

Year by year

Part D prescribing by year
20245071800% (0)4%$39,685
2023844195NoneNone$132,065
20221,051176NoneNone$151,552
20211,0861781% (12)None$210,513
20207551402% (13)None$137,487
2019587119NoneNone$86,624
2018712150NoneNone$187,677
2017857163NoneNone$198,207
20168721231% (11)None$144,540
20156701112% (11)None$49,975
20147061353% (21)15%$58,962
20137481323% (19)19%$67,696

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 24 drugs

Part D drugs prescribed in 2023
Nurtec OdtNone13$30,809$2,370
EmgalityMigraine11$8,262$751
MemantineNone108$7,295$68
Rasagiline MesylateNone16$5,237$327
PregabalinNone41$3,965$97
ZonisamideNone74$2,828$38
Memantine Hcl ErNone12$2,715$226
Carbidopa-LevodopaNone30$1,776$59
QuetiapineNone24$1,532$64
LamotrigineNone17$1,185$70
LevetiracetamNone28$1,112$40
DonepezilNone37$982$27
GabapentinNone36$860$24
BuspironeNone34$823$24
TopiramateNone14$775$55
DuloxetineNone18$749$42
ClonazepamNone26$734$28
PyridostigmineNone13$547$42
RizatriptanNone13$429$33
TrazodoneNone17$314$18
SertralineNone11$274$25
AtorvastatinNone11$114$10
Pramipexole DihydrochlorideNone11$95$9
Butalbital-Acetaminophen-CaffeNone14$36$3

2022: 25 drugs

Part D drugs prescribed in 2022
Nurtec OdtNone12$27,352$2,279
NuedextaNone15$27,075$1,805
EmgalityMigraine17$12,782$752
MemantineNone133$10,705$80
Rasagiline MesylateNone23$5,525$240
PregabalinNone84$4,581$55
Carbidopa-LevodopaNone37$3,116$84
QuetiapineNone50$2,747$55
Memantine Hcl ErNone15$2,556$170
ZonisamideNone58$2,245$39
GabapentinNone64$1,245$19
ClonazepamNone20$865$43
BuspironeNone40$827$21
LamotrigineNone22$812$37
LevetiracetamNone28$610$22
DonepezilNone52$596$11
NortriptylineNone23$377$16
Propranolol Hcl ErNone13$364$28
PropranololNone21$337$16
RizatriptanNone11$321$29
TopiramateNone15$268$18
TrazodoneNone22$211$10
Pramipexole DihydrochlorideNone15$70$5
FluoxetineNone11$67$6
Butalbital-Acetaminophen-CaffeNone15$47$3

2021: 31 drugs

Part D drugs prescribed in 2021
NuplazidParkinson's psychosis13$48,088$3,699
NuedextaNone28$47,844$1,709
RytaryParkinson's14$9,376$670
Memantine Hcl ErNone44$8,759$199
EliquisNone14$7,483$534
MemantineNone89$6,213$70
PregabalinNone115$5,094$44
Carbidopa-LevodopaNone63$4,119$65
Ropinirole ErNone20$3,909$195
Rasagiline MesylateNone11$3,169$288
GabapentinNone64$2,004$31
ZonisamideNone42$1,519$36
SumatriptanNone14$1,108$79
Levetiracetam ErNone15$1,106$74
ClonazepamNone28$1,004$36
LamotrigineNone30$900$30
TopiramateNone20$736$37
QuetiapineNone20$697$35
DuloxetineNone21$673$32
FentanylNone11$665$60
DonepezilNone51$613$12
RopiniroleNone18$570$32
LevetiracetamNone13$442$34
PropranololNone28$359$13
BuspironeNone16$335$21
DiclofenacNone13$279$21
AtorvastatinNone20$274$14
Propranolol Hcl ErNone15$237$16
SertralineNone12$187$16
TrazodoneNone12$120$10
Pramipexole DihydrochlorideNone13$40$3

2020: 20 drugs

Part D drugs prescribed in 2020
Nuedexta16$19,755$1,235
Memantine Hcl Er48$10,641$222
Rivastigmine21$10,576$504
Eliquis12$5,938$495
Sumatriptan23$4,738$206
Carbidopa-Levodopa50$3,929$79
Pregabalin49$3,488$71
Gabapentin75$2,419$32
Memantine28$2,355$84
Clonazepam21$1,250$60
Zonisamide12$1,022$85
Ropinirole19$743$39
Lamotrigine13$687$53
Rizatriptan16$682$43
Topiramate17$495$29
Donepezil46$471$10
Diclofenac13$271$21
Quetiapine13$121$9
Alprazolam12$73$6
Amlodipine Besylate15$32$2

2019: 13 drugs

Part D drugs prescribed in 2019
Rasagiline Mesylate16$17,263$1,079
Memantine Hcl Er37$14,305$387
Rivastigmine26$12,781$492
Eliquis13$6,422$494
Carbidopa-Levodopa32$4,163$130
Memantine22$1,569$71
Gabapentin86$1,221$14
Donepezil50$973$19
Quetiapine12$553$46
Lamotrigine12$348$29
Nortriptyline22$298$14
Clonazepam14$148$11
Ropinirole14$103$7

2018: 16 drugs

Part D drugs prescribed in 2018
Rasagiline Mesylate19$16,292$857
Nuedexta14$15,232$1,088
Rivastigmine23$12,488$543
Memantine Hcl Er28$10,109$361
Carbidopa-Levodopa57$3,065$54
Memantine28$1,625$58
Gabapentin74$1,303$18
Levetiracetam32$1,137$36
Donepezil86$1,110$13
Primidone29$835$29
Quetiapine47$748$16
Lamotrigine30$505$17
Levetiracetam Er11$458$42
Clonazepam16$144$9
Imipramine12$85$7
Atorvastatin11$73$7

2017: 19 drugs

Part D drugs prescribed in 2017
Nuedexta31$23,433$756
Rasagiline Mesylate33$21,641$656
Azilect19$17,090$899
Rivastigmine34$15,671$461
Namenda Xr24$15,061$628
Exelon11$15,025$1,366
Donepezil136$2,548$19
Carbidopa-Levodopa55$2,061$37
Gabapentin98$1,188$12
Levetiracetam36$1,141$32
Primidone38$731$19
Topiramate28$649$23
Quetiapine28$402$14
Tizanidine27$331$12
Lamotrigine31$327$11
Nortriptyline24$211$9
Clopidogrel14$70$5
Clonazepam13$54$4
Imipramine12$48$4

2016: 19 drugs

Part D drugs prescribed in 2016
Azilect38$31,528$830
Exelon23$12,020$523
Namenda Xr31$11,666$376
Gabapentin142$1,520$11
Carbidopa-Levodopa51$1,384$27
Donepezil112$1,276$11
Lamotrigine43$1,022$24
Levetiracetam45$844$19
Primidone46$741$16
Tizanidine37$386$10
Ropinirole15$375$25
Quetiapine29$304$10
Clopidogrel14$278$20
Verapamil14$265$19
Topiramate28$227$8
Clonazepam22$123$6
Tramadol11$77$7
Nortriptyline16$76$5
Citalopram Hbr13$24$2

2015: 16 drugs

Part D drugs prescribed in 2015
Azilect20$13,571$679
Exelon21$9,925$473
Namenda Xr12$4,793$399
Gabapentin127$1,912$15
Carbidopa-Levodopa42$1,642$39
Donepezil95$902$9
Quetiapine24$882$37
Lamotrigine31$867$28
Levetiracetam30$807$27
Primidone22$406$18
Ropinirole22$386$18
Tizanidine26$309$12
Mirtazapine14$266$19
Verapamil11$197$18
Nortriptyline17$89$5
Clonazepam16$65$4

2014: 17 drugs

Part D drugs prescribed in 2014
Azilect23$19,453$846
Exelon31$10,409$336
Mirapex Er11$5,278$480
Namenda Xr11$3,202$291
Carbidopa-Levodopa55$2,544$46
Gabapentin167$2,489$15
Levetiracetam38$1,019$27
Tizanidine43$793$18
Clopidogrel20$768$38
Donepezil55$752$14
Quetiapine22$543$25
Primidone31$502$16
Mirtazapine12$305$25
Verapamil13$201$15
Lamotrigine11$173$16
Tramadol13$140$11
Nortriptyline19$136$7

2013: 15 drugs

Part D drugs prescribed in 2013
Azilect33$24,005$727
Exelon56$18,439$329
Carbidopa-Levodopa46$2,661$58
Gabapentin170$2,475$15
Levetiracetam33$1,285$39
Clopidogrel19$1,049$55
Tizanidine60$1,024$17
Donepezil36$1,014$28
Carbidopa-Levodopa-Entacapone11$914$83
Quetiapine23$812$35
Primidone28$557$20
Mirtazapine18$346$19
Lamotrigine17$224$13
Nortriptyline22$185$8
Clonazepam11$38$3

Money from drug and device companies

$947 in 2025

Industry payments by year
2025516None$947
202422None$154
202322None$244
202257None$618
2021511None$1,050
202022None$133
2019919None$2,108

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
LundbeckVyepti$300
8 payments
  • Meals for Vyepti · 2025-12-03 · $23
  • Meals for Vyepti · 2025-10-31 · $24
  • Meals for Vyepti · 2025-07-17 · $18
  • Meals for Vyepti · 2025-06-26 · $28
  • Meals for Vyepti · 2025-05-16 · $23
  • Meals for Vyepti · 2025-04-11 · $31
  • Meals for Vyepti · 2025-02-06 · $29
  • Meals for Vyepti · 2025-01-16 · $125
Alexion PharmaceuticalsUltomiris$270
2 payments
  • Meals for Ultomiris · 2025-05-29 · $135
  • Meals for Ultomiris · 2025-05-29 · $135
Janssen BiotechNone$202
3 payments
  • Meals · 2025-11-20 · $19
  • Meals · 2025-10-02 · $150
  • Meals · 2025-09-11 · $34
Lilly USAKisunla$115
1 payment
  • Meals for Kisunla · 2025-05-14 · $115
AbbvieBotox$60
2 payments
  • Meals for Vyalev · 2025-12-16 · $27
  • Meals for Botox · 2025-03-25 · $33
See all 16 published payments
Every published payment
AbbvieMeals · 2025-12-16Vyalev$27
LundbeckMeals · 2025-12-03Vyepti$23
Janssen BiotechMeals · 2025-11-20None$19
LundbeckMeals · 2025-10-31Vyepti$24
Janssen BiotechMeals · 2025-10-02None$150
Janssen BiotechMeals · 2025-09-11None$34
LundbeckMeals · 2025-07-17Vyepti$18
LundbeckMeals · 2025-06-26Vyepti$28
Alexion PharmaceuticalsMeals · 2025-05-29Ultomiris$135
Alexion PharmaceuticalsMeals · 2025-05-29Ultomiris$135
LundbeckMeals · 2025-05-16Vyepti$23
Lilly USAMeals · 2025-05-14Kisunla$115
LundbeckMeals · 2025-04-11Vyepti$31
AbbvieMeals · 2025-03-25Botox$33
LundbeckMeals · 2025-02-06Vyepti$29
LundbeckMeals · 2025-01-16Vyepti$125
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $154

Payments by company in 2024
LundbeckVyepti$125
1 payment
  • Meals for Vyepti · 2024-12-11 · $125
AbbvieBotox$29
1 payment
  • Meals for Botox · 2024-07-19 · $29

2023: $244

Payments by company in 2023
SK Life ScienceXcopri$125
1 payment
  • Meals for Xcopri · 2023-05-31 · $125
Horizon Therapeutics plcUplizna$119
1 payment
  • Meals for Uplizna · 2023-04-17 · $119

2022: $618

Payments by company in 2022
AbbvieUbrelvy$260
3 payments
  • Meals for Ubrelvy · 2022-11-03 · $125
  • Meals for Ubrelvy · 2022-10-26 · $125
  • Meals for Ubrelvy · 2022-10-13 · $10
SK Life ScienceXcopri$125
1 payment
  • Meals for Xcopri · 2022-12-15 · $125
Alexion PharmaceuticalsSoliris$124
1 payment
  • Meals for Soliris · 2022-12-01 · $124
Horizon Therapeutics plcUplizna$97
1 payment
  • Meals for Uplizna · 2022-09-19 · $97
Impel PharmaceuticalsTrudhesa$12
1 payment
  • Education for Trudhesa · 2022-08-25 · $12

2021: $1,050

Payments by company in 2021
AbbVieUbrelvy$498
4 payments
  • Meals for Ubrelvy · 2021-11-03 · $125
  • Meals for Ubrelvy · 2021-10-28 · $124
  • Meals for Ubrelvy · 2021-06-30 · $125
  • Meals for Ubrelvy · 2021-06-02 · $124
SK Life ScienceXcopri$375
3 payments
  • Meals for Xcopri · 2021-12-01 · $125
  • Meals for Xcopri · 2021-07-13 · $125
  • Meals for Xcopri · 2021-06-10 · $125
GenzymeNone$122
1 payment
  • Meals · 2021-06-29 · $122
E.R. Squibb & Sons L.L.C.Zeposia$30
2 payments
  • Education for Zeposia · 2021-03-01 · $15
  • Education for Zeposia · 2021-03-01 · $15
Avanir PharmaceuticalsNuedexta$25
1 payment
  • Meals for Nuedexta · 2021-09-28 · $25

2020: $133

Payments by company in 2020
Teva Pharmaceuticals USAAjovy$120
1 payment
  • Meals for Ajovy · 2020-03-11 · $120
Avanir PharmaceuticalsNuedexta$13
1 payment
  • Meals for Nuedexta · 2020-03-12 · $13

2019: $2,108

Payments by company in 2019
Novartis PharmaceuticalsMayzent$739
7 payments
  • Meals for Mayzent · 2019-12-09 · $113
  • Meals · 2019-10-22 · $83
  • Meals for Mayzent · 2019-07-16 · $114
  • Meals for Mayzent · 2019-06-20 · $113
  • Meals for Mayzent · 2019-05-01 · $122
  • Meals · 2019-02-12 · $97
  • Meals for Gilenya · 2019-01-24 · $97
Teva Pharmaceuticals USAAjovy$342
3 payments
  • Meals for Austedo · 2019-10-19 · $117
  • Meals for Ajovy · 2019-03-21 · $111
  • Meals for Ajovy · 2019-02-02 · $114
LundbeckNorthera$232
2 payments
  • Meals for Northera · 2019-09-12 · $107
  • Meals for Northera · 2019-05-29 · $125
GenzymeAubagio$200
2 payments
  • Meals for Aubagio · 2019-08-07 · $83
  • Meals for Aubagio · 2019-04-22 · $117
Portola PharmaceuticalsAndexxa$125
1 payment
  • Meals for Andexxa · 2019-05-23 · $125
AmgenAimovig$125
1 payment
  • Meals for Aimovig · 2019-03-14 · $125
Lilly USANone$123
1 payment
  • Meals · 2019-01-17 · $123
Alexion PharmaceuticalsSoliris$121
1 payment
  • Meals for Soliris · 2019-08-29 · $121
Genentech USAOcrevus$100
1 payment
  • Meals for Ocrevus · 2019-11-07 · $100

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
96.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1417169491
Licence
CA A97089, IL 036-117540California A97089: Current · expires 2028-05-31Illinois 036117540: Not Renewed
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Neurology (2084N0400X)
Mailing address
325 Distel Cir, Los Altos, CA, 94022
NPI first listed
2007-05-04
NPI last updated
2026-07-25
NPI record certified
2026-07-25

This is when the NPI record was last certified, not a medical board exam.